New transparency policies that enable greater data sharing will advance global health

Over the course of the COVID-19 pandemic, scientists from the U.S. Food and Drug Administration (FDA) generated large amounts of data through their review of pandemic-related tests, medications, and vaccines.
Over the course of the COVID-19 pandemic, scientists from the U.S. Food and Drug Administration (FDA) generated large amounts of data through their review of pandemic-related tests, medications, and vaccines.